As of 2024-12-15, the Relative Valuation of BioLife Solutions Inc (BLFS) is (18.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.70 USD, the upside of BioLife Solutions Inc based on Relative Valuation is -167.5%.
The range of the Relative Valuation is (15.46) - (15.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 25.7x | 20.4x |
| Forward P/E multiples | 15.5x - 16.0x | 15.8x |
| Fair Price | (15.46) - (15.96) | (18.03) |
| Upside | -157.9% - -159.8% | -167.5% |
| Date | P/E |
| 2024-12-13 | -26.49 |
| 2024-12-12 | -26.79 |
| 2024-12-11 | -26.39 |
| 2024-12-10 | -26.27 |
| 2024-12-09 | -26.34 |
| 2024-12-06 | -26.31 |
| 2024-12-05 | -25.24 |
| 2024-12-04 | -26.45 |
| 2024-12-03 | -26.88 |
| 2024-12-02 | -27.34 |
| 2024-11-29 | -27.54 |
| 2024-11-27 | -27.23 |
| 2024-11-26 | -27.13 |
| 2024-11-25 | -26.84 |
| 2024-11-22 | -26.07 |
| 2024-11-21 | -25.45 |
| 2024-11-20 | -25.07 |
| 2024-11-19 | -22.50 |
| 2024-11-18 | -20.52 |
| 2024-11-15 | -21.07 |
| 2024-11-14 | -21.70 |
| 2024-11-13 | -24.17 |
| 2024-11-12 | -26.57 |
| 2024-11-11 | -26.67 |
| 2024-11-08 | -26.20 |
| 2024-11-07 | -26.21 |
| 2024-11-06 | -26.67 |
| 2024-11-05 | -25.98 |
| 2024-11-04 | -25.62 |
| 2024-11-01 | -24.13 |
| 2024-10-31 | -23.46 |
| 2024-10-30 | -24.12 |
| 2024-10-29 | -23.65 |
| 2024-10-28 | -22.92 |
| 2024-10-25 | -22.09 |
| 2024-10-24 | -21.66 |
| 2024-10-23 | -21.99 |
| 2024-10-22 | -22.67 |
| 2024-10-21 | -23.07 |
| 2024-10-18 | -23.69 |
| 2024-10-17 | -23.20 |
| 2024-10-16 | -23.01 |
| 2024-10-15 | -23.50 |
| 2024-10-14 | -23.50 |
| 2024-10-11 | -22.66 |
| 2024-10-10 | -22.26 |
| 2024-10-09 | -23.46 |
| 2024-10-08 | -23.80 |
| 2024-10-07 | -24.01 |
| 2024-10-04 | -24.60 |